Insulet (PODD) Current Deferred Revenue (2010 - 2019)
Insulet's (PODD) quarterly Current Deferred Revenue came in at $1.2 million in Q1 2019, down 57.46% on a YoY basis from $2.8 million in Q1 2018, and up 0.93% quarter-over-quarter from $1.2 million in Q4 2018.
Analysis
Insulet (PODD) Current Deferred Revenue (2010 - 2019) Analysis & Trends
Insulet (PODD) has reported Current Deferred Revenue for 10 consecutive years, with $1.2 million the latest figure, recorded in Q1 2019.
- For the quarter ending Q1 2019, Current Deferred Revenue fell 57.46% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2019 stood at $1.2 million (down 57.46% YoY), and the FY2018 full-year result was $1.2 million, down 49.75% from the prior year.
- Current Deferred Revenue advanced to $1.2 million in Q1 2019 per PODD's latest filing, from $1.2 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $2.8 million in Q1 2018 and bottomed at $1.2 million in Q4 2018.
- Historically, Current Deferred Revenue has averaged $2.0 million across 5 years, with a median of $2.0 million in 2017.
- The sharpest annual moves came in 2015 and 2019: Current Deferred Revenue soared 210.46% in 2015, then plunged 57.46% in 2019.
- Over 5 years, Current Deferred Revenue stood at $2.5 million in 2015, then fell by 24.0% to $1.9 million in 2016, then rose by 24.0% to $2.4 million in 2017, then plunged by 49.75% to $1.2 million in 2018, then gained by 0.93% to $1.2 million in 2019.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.2 million, $1.2 million, and $2.2 million for Q1 2019, Q4 2018, and Q3 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 1.20 Mn |
| Dec 31, 2018 | 1.18 Mn |
| Sep 30, 2018 | 2.21 Mn |
| Jun 30, 2018 | 2.34 Mn |
| Mar 31, 2018 | 2.81 Mn |
| Dec 31, 2017 | 2.36 Mn |
| Sep 30, 2017 | 2.60 Mn |
| Jun 30, 2017 | 2.00 Mn |
| Mar 31, 2017 | 1.80 Mn |
| Dec 31, 2016 | 1.90 Mn |
| Sep 30, 2016 | 1.80 Mn |
| Jun 30, 2016 | 1.70 Mn |
| Mar 31, 2016 | 1.70 Mn |
| Dec 31, 2015 | 2.50 Mn |
| Sep 30, 2015 | 2.40 Mn |
| Jun 30, 2015 | 2.30 Mn |
| Mar 31, 2015 | 1.90 Mn |
| Dec 31, 2014 | 1.60 Mn |
| Sep 30, 2014 | 834,000.00 |
| Jun 30, 2014 | 1.30 Mn |